Hospira Asks Full Fed. Circ. To Settle Split On Inherency

Hospira has asked the full Federal Circuit to decide when patents can be invalidated as inherently obvious, as part of the Pfizer unit's fight with Fresenius Kabi over a sedative patent...

Already a subscriber? Click here to view full article